StandardPoorly
Ticker · NMS

VTRS · Viatris Inc.

Healthcare · Drug Manufacturers - Specialty & Generic

Viatris Inc.

NMS · Healthcare / Drug Manufacturers - Specialty & Generic
All sectors →
VTRS
$16.07
-1.38%
7-day move
day$15.88 $16.1552-wk$8.44 $17.53avg vol10.9M / 3Mcap$18.7B
Plate I.

The Past Year, in One Line

$12$13$14$15$16202120222023202420252026$16.07VTRS
The Valuation
P/E (forward)6.0
P/E (trailing)
EPS (forward)$2.68
EPS (trailing)$-0.30
PEG0.15
Dividend3.02%
The Risk
Beta0.90
Short % float3.28%
Float1.16B
Shares out1.16B
Avg vol (3M)10.9M
52w range$8.44 → $17.53
The Analyst Tape
strong buybuyholdunderperformsell
$18.06
avg 12-mo target
+12.4%
vs. last · 9 analysts
At a Glance
$18.7B
market cap (USD)
exchangeNMS
sectorHealthcare
industryDrug Manufacturers - Specialty & Generic
market cap$18.7B
websiteviatris.com

The Briefs

live, polled every 60 seconds · Alpaca / Benzinga
No recent headlines for VTRS in the last 7 days.

Word on the Street

StockTwits public feed · self-tagged bull/bear
No recent StockTwits posts for VTRS.

Indicators That Mention VTRS

8 of our 639 catalog map to VTRS
SP-1139
AbbVie
Pharma mega-cap. Production tell via epa_abbv_waste.
49%
49%
49%
49%
52%
48%
Still works on fresh data
r=-0.10
SP-2967
XLV Healthcare ETF
Healthcare SPDR — pharma + biotech + insurers + devices. Broader than UNH alone.
49%
49%
50%
49%
50%
51%
Still works on fresh data
r=-0.03
SP-1253
Pfizer
Big pharma. Vaccine + small-molecule production via epa_pfe_waste.
49%
49%
50%
49%
49%
49%
Still works on fresh data
r=-0.02
SP-1346
UnitedHealth Group
Biggest US health insurer. Pricing power = consumer cost forecast.
49%
49%
49%
49%
50%
51%
Still works on fresh data
r=-0.04
SP-3489
ABBV TRI Chemical Releases
Annual chemical releases from AbbVie US plants. Pharma batch chemistry.
50%
50%
50%
50%
50%
50%
Too new to retest
r=0.00
SP-3062
AbbVie Hazardous Waste Tonnage
Monthly hazardous waste from AbbVie US plants. Drug batch chemistry, mixed-clean signal.
50%
50%
50%
50%
50%
50%
Not yet retested on fresh data
r=0.00
SP-3534
LLY TRI Chemical Releases
Annual chemical releases from Eli Lilly US plants. Pharma production (incl. GLP-1).
50%
50%
50%
50%
50%
50%
Too new to retest
r=0.00
SP-3555
MRK TRI Chemical Releases
Annual chemical releases from Merck US plants. Pharma + vaccine production.
50%
50%
50%
50%
50%
50%
Too new to retest
r=0.00
Standard Poorly Disclaimer
We tested 639 indicators against four horizons. By chance alone, ~128 of these correlations should look "significant." Walk-forward out-of-sample is the only thing we trust.

Other Players in the Pipeline

Healthcare · by market cap · 7-day move
Metadata last refreshed 2026-06-05T14:13:34.518051+00:00 via yfinance. Price figures are end-of-day; intraday quotes are not surfaced on the free tier. We don't provide investment advice — see methodology for what we do and don't claim.

Voices on VTRScommentarylive

Curated commentary (Kobeissi, Doomberg, Lyn Alden, QuoteTheRaven, Pomp, ZeroHedge) mentioning VTRS. Opinion, not wire.
No recent commentary mentioning VTRS in the last 7 days.
Analyst · previewYou're seeing the public read on VTRS. Analyst unlocks every pundit call on VTRS with open P&L + alerts when a new position opens + the full related-indicator firing history. Trader adds intraday quotes + cross-asset co-fire scoring with VTRS as the target + the API / MCP feed.Compare tiers →